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Herein, the structural effect of autologous platelet-rich plasma (PRP) on posttraumatic skeletal muscle regeneration in rats with
chronic hyperglycemia (CH) was tested. 130 white laboratory male rats divided into four groups (I—control; II—rats with CH;
III—rats with CH and PRP treatment; and IV—rats for CH confirmation) were used for the experiment. CH was simulated by
streptozotocin and nicotinic acid administration. Triceps surae muscle injury was reproduced by transverse linear incision.
Autologous PRP was used in order to correct the possible negative CH effect on skeletal muscle recovery. On the 28th day after
the injury, the regenerating muscle fiber and blood vessel number in the CH+PRP group were higher than those in the CH rats.
However, the connective tissue area in the CH group was larger than that in the CH+PRP animals. The amount of
agranulocytes in the regenerating muscle of the CH rats was lower compared to that of the CH+PRP group. The histological
analysis of skeletal muscle recovery in CH+PRP animals revealed more intensive neoangiogenesis compared to that in the CH
group. Herewith, the massive connective tissue development and inflammation signs were observed within the skeletal muscle of
CH rats. Obtained results suggest that streptozotocin-induced CH has a negative effect on posttraumatic skeletal muscle
regeneration, contributing to massive connective tissue development. The autologous PRP injection promotes muscle recovery
process in rats with CH, shifting it away from fibrosis toward the complete muscular organ repair.
1. Introduction
Skeletal muscle injuries account for about 30% of all occupa-
tional diseases in industrialized countries [1]. Muscle trauma
is also one of the main reasons for the decline of athlete com-
petition performance [2]. Therefore, uncovering the cellular
and molecular mechanisms of skeletal muscle regeneration
and the development of effective ways of muscle recovery
improvement are the important tasks of modern medical sci-
ence [3].
Currently, chronic hyperglycemia (CH) is one of the
most common metabolic disorders worldwide [4]. CH is
associated with the development of secondary complications
in skeletal muscle and may impair its regeneration capacity.
Experimental studies have shown that CH attenuates the
expression of muscle-specific transcription factors (MyoD
and myogenin) [5] and reduces the number of myosatellite
cells (MSCs) in both animal and human skeletal muscle
[6, 7]. Jeong et al. have shown that MSCs derived from rats
with streptozotocin-induced diabetes mellitus (DM) are
incapable of myotube formation [8]. Also, rats with genetic
DM models have a significant delay and incompleteness of
posttraumatic skeletal muscle regeneration [9, 10].
Platelet-rich plasma (PRP) is one of the promising
therapeutic agents capable of enhancing regeneration of
various tissues and organs, including striated muscles.
Wright-Carpenter et al. [11] revealed that autologous condi-
tioned serum administration promotes MSC activation and
increases the size of the regenerating fibers within injured
skeletal muscle. Gigante et al. [12] had found that platelet-
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rich fibrin matrix improves regeneration and promotes neo-
vascularization in striated muscle after mechanical lesion.
Several studies have also shown that PRP administration
reduces the regeneration time and improves histologic out-
come and functional recovery of the skeletal muscle [13–16].
Hamid et al. [17] showed that PRP is able to accelerate
the recovery of injured skeletal muscle in athletes. Nitecka-
Buchta et al. [18] have reported that PRP injection into the
masseter muscle reduces pain in patients with temporoman-
dibular disorders. However, a few systematic reviews have
failed to conclude on PRP effectiveness and safety for human
muscular injury treatments [19–21].
PRP does have a positive effect on soft tissue repair in
patients with DM. The results of meta-analysis have shown
that PRP significantly improves wound healing and acceler-
ates functional recovery in patients with diabetic foot
syndrome [22–24]. Regrettably, there is no current work
devoted to investigation of the PRP effect on skeletal mus-
cle regeneration under CH influence.
The aim of the study was to investigate the structural
effects of autologous PRP on posttraumatic skeletal muscle
regeneration in rats with CH.
2. Materials and Methods
2.1. Animals. 130 white laboratory male rats (age—7-9
months) were used for the experiment. All the animals were
divided into four groups: I—control group (40 rats with
skeletal muscle injury); II—CH group (40 animals with
simulated CH and skeletal muscle injury); III—CH+PRP
group (40 rats with simulated CH and skeletal muscle
injury, which received PRP injection into muscle damage
area); and IV—CH confirmation group (10 animals with
CH for glucose homeostasis evaluation).
All the animals, participating in the test, were examined
for motor activity and outer covering condition. Then, rats
were subjected to a two-week quarantine. The experimental
animals were used according to policies of general ethical
principles of experiments on animals (Kyiv 2001), Declara-
tion of Helsinki (2000), European Convention for the Protec-
tion of Vertebrate Animals used for Experimental and Other
Scientific Purposes (Strasbourg 1985). Ethics and morality
were not violated during the research. Rats were housed in
the vivarium room under constant temperature (24-25°C),
humidity (60 ± 5) %, and 12-hour dark-light cycle. Cage
cleaning was performed daily.
2.2. Simulation of Chronic Hyperglycemia and Muscle
Trauma. The rats of II, III, and IV groups have been con-
suming 10% aqueous fructose solution instead of drinking
water for 2 weeks. Then, a single intraperitoneal injection
of streptozotocin (40mg/kg, Sigma-Aldrich, USA), dissolved
in citrate buffer (pH4.5), and nicotinic acid (1mg/kg) for
each animal was performed. Each control rat received a sin-
gle intraperitoneal citrate buffer (pH4.5) injection. Following
streptozotocin or vehicle administration, animals were
placed under normal vivarium conditions with a normal diet
(food and water ad libitum) for 60 days.
Animals of the IV group were used to assess glucose
homeostasis and to confirm the CH. Fasting glucose level,
insulin, and C-peptide concentration were determined in
the blood of these rats on the 60th day after CH simulation.
Obtained data were used to confirm the CH presence.
2.3. Skeletal Muscle Injury. The injury model was modified
from a rat model described by Tsai et al. [16]. The trauma
of triceps surae muscle was reproduced in rats of I, II, and
III groups 60 days after CH simulation. Surgery was
performed in aseptic conditions under ketamine (8mg/kg)
and xylazine (3mg/kg) anesthesia. The mechanical injury
was applied by transverse linear incision of a lateral head of
the triceps surae muscle at a point that is 40% distal to its
origin. Ophthalmic knife (blade width—1.8mm; blade
length—4.5mm) was used for traumatization. The defect
width was approximately 75% of the muscle width; the defect
depth was approximately 50% of the muscle thickness. At the
end of the operation, the wound edges were matched and the
skin was sutured.
2.4. PRP Preparation. A recent study showed that PRP
promotes muscle regeneration and decreases inflammation
and apoptosis in the injury model described above [16].
This allowed us to move forward and evaluate the effects
of PRP on muscle recovery in rats with this injury model
in the context of CH. In order to correct a possible negative
CH effect on skeletal muscle regeneration, the autologous
PRP (250μl) was injected into the wound of III group ani-
mals before the suturing. Previously, 0.8ml of blood from
the lateral tail vein was collected into vacutainers containing
sodium citrate solution. The lost blood volume was immedi-
ately restored by sterile saline infusion. The selected blood
was centrifuged (20min; speed—2,000 rpm). As a result,
two blood component fractions were observed in the test
tube: lower dark red fraction (cellular components) and an
upper straw yellow fraction (serum components). The upper
fraction and upper portion of the lower fraction were pipet-
ted and transferred to another tube. The resulting material
was centrifuged (15min; speed—2,000 rpm), which led to
the formation of two fractions: lower, platelet-rich plasma,
and upper, platelet-poor plasma. The lower fraction was
transferred to a sterile tube, and the volume was adjusted to
0.5ml with 10% calcium chloride solution [25]. The resulting
solution was injected into the muscle wounds of III group
animals. Each animal received its own (autologous) plasma.
2.5. Histology and Morphometry. The morphological features
of skeletal muscle regeneration in I, II, and III groups were
studied on the 3rd, 7th, 14th, and 28th day after receiving
the mechanical injury. Animals were removed from the
experiment (10 rats per term) by thiopental anesthesia over-
dose (4mg/100 g body weight).
The portions of injured skeletal muscles were fixed in a
10% formalin solution in order to study the microscopic
structure. The samples were dehydrated in alcohols of
increasing concentration and then placed into paraffin.
Transverse sections (across the muscle fibers) were made
using MC-2 microtome (thickness—4-6μm). The staining
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was performed with hematoxylin-eosin (to evaluate the
number and cross-sectional area of different muscle fibers,
to determine vessel number, and to assess the inflammatory
infiltration) and picrosirius red (to evaluate the collagen
content and its formation dynamics). Semithin sections
(thickness—1μm) stained with methylene blue were also
made to visualize and count different white blood cells.
The lateral head of triceps surae muscle sampling in each
group was performed on all 10 rats.
An Olympus BH-2 microscope (Japan) was used for
light microscopy. Images of histological specimens were
performed using a Baumer/Optronic Typ: CX 05c digital
camera. The morphometric analysis was done using micro-
grid, microwave line, and Digimizer computing software
(version 5.3.5). All muscle fibers were divided into three
types: normal muscle fibers (NMF)—typical muscle fibers
without injury signs; damaged muscle fibers (DMF)—fibers
with atypical shape and size along with signs of damage;
and regenerating muscle fibers (RMF)—centrally nucleated
fibers. Two-dimensional analysis of cross-sectional samples
was carried out to determine the number of DMF (no./mm2),
RMF (no./mm2), vessels (no./field), the regeneration area, the
connective tissue area, granulocyte (no./mm2), and agranulo-
cyte number (no./mm2). The regeneration area was calcu-
lated as the percentage of regenerating fibers from the total
muscle fiber area. Connective tissue area was defined as the
percentage of connective tissue area of the total muscle
cross-sectional area. The qualitative summary assessment of
the following histopathological changes was also carried
out: necrosis (muscle fibers with impaired membrane integ-
rity, vacuolization, and sarcoplasm disorganization); connec-
tive tissue edema (increasing of connective tissue spaces
without signs of new fiber formation); inflammatory infiltra-
tion (amount of white blood cells); vascularization (number
of vessels); fibrosis (area of new collagen fibers); and a num-
ber of centrally nucleated muscle fibers.
2.6. Statistical Analysis.Mathematical analysis was performed
using SPSS (version 17.0, USA). Continuous data are pre-
sented as mean ðMÞ ± standard deviation ðSDÞ. Kolmogorov-
Smirnov test was used to check the normality distribution.
The significance of differences between groups was deter-
mined using Student’s t-criterion and one-way ANOVA
followed by Bonferroni post hoc test. P values < 0.05 were
considered statistically significant.
3. Results
The results of blood biochemical analysis of control (group I)
and experimental animals (group IV) on the 60th day
after CH simulation are shown in Table 1. Rats with
streptozotocin-induced CH had significantly higher fasting
glucose level (P < 0:001) and decreased insulin content
(P = 0:005). The C-peptide amount did not differ between
comparison groups (P = 0:267). CH rats also had higher
concentration of total cholesterol (P < 0:001), triglycerides
(P < 0:001), and LDL (P < 0:001) and decreased HDL level
(P = 0:004). Obtained changes largely correspond to the
type 2 DM phenotype.
The results of estimating the muscle fibers and vessel
amount in skeletal muscle of different groups on 3rd, 7th,
14th, and 28th days after mechanical injury are presented
in Table 2. The significant difference in the mean values
of all studied parameters between rats of I, II, and III
groups was revealed at each experiment time (according
to ANOVA). The results of post hoc test on the 28th
day after injury showed that DMF number in control rats
was lower compared to that in CH (by 68.4%; P < 0:001)
and CH+PRP group (by 53.8%; P < 0:001). DMF number
in animals with CH was higher than that in CH+PRP rats
(by 31.6%; P < 0:001). In contrast, the RMF and blood
vessel number on the 28th day after injury in control ani-
mals was higher compared to that in CH rats (by 26.8%;
P < 0:001—for RMF; by 40%; P < 0:001—for vessels) and
CH+PRP rats (by 7.9%; P = 0:030—for RMF; by 7.4%;
P = 0:041—for vessels). The RMF (by 20.5%; P < 0:001)
and blood vessel (by 35.2%; P < 0:001) amount in the
CH+PRP group was higher than that in the CH group.
The morphometric analysis also included calculations on
the area of regeneration and connective tissue (Figure 1). The
regeneration area in rats with CH was significantly smaller
compared to that in control animals (by 60.8%; P < 0:001
—on the 14th day; by 32.6%: P < 0:001—on the 28th day)
and the CH+PRP group (by 50.7%; P < 0:001—on the 14th
day; by 22.6%; P < 0:001—on the 28th day). A significant
difference in connective tissue area was revealed only on
the 28th day after muscle lesion. Thus, the connective tis-
sue area in the CH group was larger than that in control
rats (by 15.6%; P = 0:014) and CH+PRP animals (by
22.1%; P = 0:001).
One of the key components of successful skeletal muscle
regeneration is the quality and proper sequence of inflamma-
tion development. Thence, the granulocyte and agranulocyte
numbers in regenerating muscle were calculated (Figure 2).
During the whole period of muscle recovery, the granulocyte
amount was found to be significantly higher in rats with CH
compared to control and CH+PRP group (P < 0:05). In
contrast, the agranulocyte content in CH rats was lower than
that in control animals and CH+PRP rats (P < 0:05).
The results of histological analysis in all studied groups
are shown in Figure 3. The pronounced muscle fiber necrosis,




(n = 10) CH (n = 10) P
Fasting glucose (mmol/l) 4:97 ± 0:73 14:76 ± 1:87 <0.001
Total cholesterol (mmol/l) 1:89 ± 0:21 3:26 ± 0:36 <0.001
Triglycerides (mmol/l) 0:54 ± 0:11 1:03 ± 0:16 <0.001
LDL (mmol/l) 0:59 ± 0:08 0:93 ± 0:12 <0.001
HDL (mmol/l) 1:92 ± 0:20 1:48 ± 0:21 0.004
Insulin (μMU/ml) 16:01 ± 1:81 12:35 ± 1:77 0.005
С-peptide (ng/ml) 3:47 ± 0:79 3:96 ± 0:64 0.267
LDL: low-density lipoproteins; HDL: high-density lipoproteins; CH:
experimental chronic hyperglycemia. Data are presented as means ± SD.
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tissue swelling, blood vessel plethora, and leukocyte infiltra-
tion were observed in control rats on the 3rd day after injury
(Figure 3(a)). On the 7th day, the large number of fibroblasts
and massive collagen fiber formation were detected in the
control group (Figure 3(d)). Tissue swelling and leukocyte
infiltration were also maintained. On the 14th day, the
new muscle fiber formation and significant angiogenesis
activation were observed. The slight edema and leukocyte
infiltration were also detected. On the 28th day, the histo-
logical picture of skeletal muscle recovery in control
animals was characterized by fibromuscle regenerate devel-
opment. There was a massive extracellular matrix forma-
tion around CNFs. A significant number of vessel was
also observed (Figures 3(g) and 3(j)).
The pattern of muscle regeneration in rats with CH on
the 3rd and 7th day after the muscle injury was mostly
similar to control animals. However, relatively small vessel
number, lipid accumulation, more pronounced inflamma-
tion, and connective tissue development were observed
(Figures 3(b) and 3(e)). On the 14th day, tissue swelling
and significant leukocyte infiltration in CH rats were
detected. Necrosis sites together with small newly formed
fiber number were observed (Figure 3(h)). On the 28th
day, there were massive fibrosis and a relatively small
number of newly formed vessels in rats with CH. Muscle
fibers had a relatively small area. At the same time,
inflammatory infiltration persisted (Figure 3(k)).
The histological picture of muscle regeneration in CH
+PRP animals on the 3rd day after lesion mostly corre-
sponded to the CH group. However, on the 7th day, edema
and leukocyte infiltration were less pronounced and angio-
genesis activity was more noticeable in CH+PRP rats
Table 2: The number of muscle fibers and vessels in the injured skeletal muscle.
Parameter Group 3 days 7 days 14 days 28 days
Damaged fibers (no./mm2)
Control 210:4 ± 15:9 202:7 ± 23:7 197:2 ± 12:9 47:4 ± 3:5
CH 227:4 ± 14:6 225:4 ± 14:1 283:3 ± 18:9 150:1 ± 14:1
CH+PRP 212:8 ± 12:9 193:8 ± 21:7 206:0 ± 32:7 102:6 ± 4:6
P 0.030 0.005 <0.001 <0.001
Regenerating fibers (no./mm2)
Control — 22:5 ± 2:8 211:5 ± 14:1 512:3 ± 38:8
CH — 5:9 ± 0:3 92:9 ± 6:2 375:0 ± 35:2
CH+PRP — 15:7 ± 1:8 170:2 ± 26:9 471:9 ± 21:2
P — <0.001 <0.001 <0.001
Vessels, (no./field)
Control 10:7 ± 0:8 11:2 ± 1:5 19:2 ± 1:4 27:0 ± 2:1
CH 7:5 ± 0:5 7:3 ± 0:7 11:6 ± 0:8 16:2 ± 1:5
CH+PRP 9:8 ± 0:6 9:4 ± 1:1 16:3 ± 2:6 25:0 ± 1:3
P <0.001 <0.001 <0.001 <0.001
Data are presented asmeans ± SD. CH: chronic hyperglycemia; PRP: platelet-rich plasma; P: possibility by Fisher F-criterion. Results of Bonferroni post hoc test






























































Figure 1: (a) Percentage regenerating area of total muscle fiber cross-sectional area on the 14th and 28th day after injury. (b) Percentage of
connective tissue area of total muscle organ cross-sectional area on the 3rd, 7th, 14th, and 28th day after injury. ∗Significant difference by
ANOVA.
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compared to animals with CH (Figures 3(c) and 3(f)). On
the 14th day, the massive new muscle fiber formation,
blood vessel plethora, and inflammation were detected
(Figure 3(i)). On the 28th day, the muscle regeneration
process in CH+PRP animals was characterized by the large
number of new vessels and by massive fibrosis around the
CNFs (Figure 3(l)).
A summary of the qualitative assessment of posttrau-
matic skeletal muscle regeneration in rats of comparison
groups is presented in Table 3.
4. Discussion
The structural features of skeletal muscle regeneration in
rats with CH, as well as morphological analysis of PRP
effect on the striated muscle recovery in animals with CH,
were investigated. Mechanical injury by transverse linear
incision was used for the experiment. The process of mus-
cle regeneration after the incision had several differences
compared to regeneration after injury by chemical agents
[10, 26], temperature [26], contusion [11], or straining
[14]. Necrosis and inflammation prolongation, as well as
massive connective tissue development, were observed.
Eventually, the regeneration process has culminated in the
formation of fibromuscle regenerate. Herewith, after cardi-
otoxin [26, 27] or straining [14] injury, complete skeletal
muscle regeneration practically repeats the morphological
picture of this organ before the trauma.
Histomorphometric analysis of skeletal muscle regenera-
tion in rats with CH revealed several salient features. Thus,
edema and leukocyte infiltration were observed even 28 days
after injury. Herewith, granulocyte predominance and
reduced agranulocyte numbers were observed. Similar results
were obtained by Krause et al., which showed the decreased
macrophage number within regenerating muscles of rats
with type 1 DM [9]. Nguyen et al. also have revealed reduced
macrophage amount inside skeletal muscle regenerates of
rats with a genetic model of type 2 DM [10]. Recent studies
have shown that macrophages are the prerequisite for suc-
cessful skeletal muscle regeneration [28]. Macrophages act
as an important regulatory factor in the process of muscle-
specific cambial cell activation [29, 30]. Xiao et al. [31]
have shown that macrophage depletion leads to excessive
connective tissue development and size reduction of newly
formed muscle fibers during skeletal muscle regeneration.
Skeletal muscle regeneration in rats with CH was charac-
terized by significantly reduced new vessel formation, which
was also found in animals with a genetic model of type 2 DM
[10]. Today, there is no single explanation of angiogenesis
impairment within skeletal muscle under CH condition
[32–34]. But it is likely that restricted blood supply due to
disrupted neoangiogenesis is an important factor of incom-
plete posttraumatic muscle regeneration.
CH inhibits the MyoD and myogenin expression [5] and
leads to MSC reduction in the skeletal muscle [6, 7]. Our
results revealed the decrease in amount and total area of
newly formed fibers within regenerating striated muscle of
rats with CH. Jeong et al. also have shown a significant
decrease in CNF number during posttraumatic muscle
regeneration in rats with streptozotocin-induced diabetes
[8]. In addition, skeletal muscle regeneration in rats with
genetic DM models was also associated with a significant
decrease in MSC activity and number [9, 10].
Skeletal muscle recovery in rats with CH was character-
ized also by incompleteness, fat inclusion accumulation,
and massive collagen fiber formation, which largely corre-
sponds to results obtained in other similar studies [8–10].
Thus, our results revealed the histopathological signs of
CH negative effect on muscle regeneration in rats with a
mechanical muscle injury. Currently, some molecular mech-
anisms of CH influence on skeletal muscle repair are
described. The experimental DM induces overactivation of
myostatin/TGF-β receptor signaling, which in turn inhibits























































Figure 2: Amount of white blood cells (agranulocytes and granulocytes) in the skeletal muscle on the 3rd, 7th, 14th, and 28th day after the
mechanical injury. Data are presented as means ± SD. ∗Significant difference by ANOVA.
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Figure 3: Histology of skeletal muscle regeneration in control (a, d, g, j), chronic hyperglycemia (b, e, h, k), and chronic hyperglycemia
+platelet-rich plasma (c, f, i, l) groups on the 3rd, 7th, 14th, and 28th day after mechanical injury. Explanations are in the text.
Staining—hematoxylin and eosin. Scale bar—50μm.
Table 3: Qualitative assessment of skeletal muscle regeneration.
3 days 7 days 14 days 28 days
Ctrl CH CH+PRP Ctrl CH CH+PRP Ctrl CH CH+PRP Ctrl CH CH+PRP
Necrosis +++ +++ +++ ++ +++ ++ – + – – – –
Connective tissue edema ++ +++ +++ + +++ + + ++ + – + –
Inflammatory infiltration +++ +++ +++ + +++ ++ + ++ + – + –
Vascularization ++ + ++ ++ + ++ +++ ++ ++ +++ ++ +++
Fibrosis + + + ++ ++ ++ ++ ++ ++ ++ +++ ++
CNFs – – – + – + ++ + ++ +++ ++ +++
Ctrl: control group; CH: rats with chronic hyperglycemia; CH+PRP: rats with chronic hyperglycemia+platelet-rich plasma injection; CNFs: centrally nucleated
fibers. The results are expressed as a percentage of the highest value among all groups: (–) rare or not detected; (+) between 10% and 30%; (++) between 30% and
60%; (+++) over 60%.
6 BioMed Research International
It was also demonstrated that diabetes results in MSC con-
tent and functionality decline due to hyperactivation of the
Notch signaling pathway [6]. It is not yet known, whether
CH, insulin signaling disruption, or both are the reason for
MSC regenerative response impairment. It was also shown
that several proinflammatory factors (e.g., interleukin-6
and tumor necrosis factor-α) are elevated in diabetic patients
[35]. This may be a result of advanced glycation end product
overformation [36]. Moreover, in vitro experiments revealed
that the hyperglycemic environment induces adipogenic dif-
ferentiation of muscle-derived stem cells [37]. It is assumed
that reactive oxygen species and downstream effector
kinases, such as PKC-β, play the main role in this process.
All the data, gathered above, can serve as an attempt to sub-
stantiate the reduction of new muscle fiber amount, inflam-
mation deregulation, and adipocyte presence in regenerating
muscles of rats with streptozotocin-induced CH.
A recent review by Setayesh et al. [38] showed that PRP
promotes skeletal muscle regeneration through growth fac-
tors secreted from activated platelets. Aydin et al. demon-
strated that PRP could improve the histopathological
grades in wound healing suppressed by corticosteroid [39].
In addition, a few meta-analyses have shown that topical
PRP application for diabetic ulcer treatment accelerates
wound healing and significantly reduces the number of com-
plications [22–24]. Given the abovementioned, we have
decided to investigate the PRP effect on skeletal muscle
regeneration in rats with CH.
The results of the histological analysis showed the differ-
ence in severity (leukocyte infiltration, edema presence) and
quality (granulocyte and agranulocyte number) of inflamma-
tion between the CH+PRP group and CH rats, wherein the
results in the CH+PRP group were almost the same as in
the control. Tsai et al. also demonstrated the reduced amount
of CD68-positive and apoptotic cells in the injured skeletal
muscle treated with PRP [16]. However, Gigante et al. [12]
revealed no difference in the inflammation manifestation
during skeletal muscle regeneration between PRP-injected
rats and rats without PRP using.
The PRP administration into the skeletal muscle of rats
with CH also resulted in neoangiogenesis activation. The ves-
sel number in the regenerating muscle of CH+PRP rats was
almost the same as in the control group. The neoangiogenesis
intensification during muscular recovery due to PRP using
was also revealed by Gigante et al. [12]. The results of our
study also showed that PRP contributes to increase of CNF
number and total regeneration area in the skeletal muscle
of rats with CH. The increase in the number of newly formed
fibers during muscle recovery due to PRP injection has also
been identified in several studies on animals with different
types of mechanical muscle injury [13–15]. These studies
also reported collagen area and fibrosis degree reduction
in striated muscle regenerates due to PRP administration.
Our results also showed that the connective tissue area
in CH+PRP rats was smaller compared to that in CH rats.
This is the first report about PRP structural effect on
skeletal muscle regeneration in rats with experimental
CH. The obtained results revealed that PRP could enhance
striated muscle recovery under CH conditions. However,
our research had a few important limitations, which have
to be taken into consideration. Firstly, the concentration
of growth factors and cytokines was not evaluated in the
prepared PRP. Secondly, the immunohistochemistry and
confocal microscopy were not used. These would have
made the evaluation of the neoangiogenesis nature, as well
as the cellular composition of regenerating muscles, much
more accurate. Thirdly, no molecular-genetic techniques,
such as RT-PCR, have been applied to evaluate the CH
and PRP effect on specific transcription factor expression.
Finally, no analysis of dynamic and strength indices of
regenerating skeletal muscle were performed, which made
it impossible to assess functional recovery in the compari-
son groups.
5. Conclusion
Thus, the streptozotocin-induced CH has a negative impact
on posttraumatic striated muscle regeneration, contributing
to massive connective tissue development instead of new
muscle fiber formation. The autologous PRP injection pro-
motes the skeletal muscle recovery process in rats with CH,
shifting it away from fibrosis toward the complete muscular
organ formation.
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